WO2000014541A1 - Method for screening ligand affinity and tool for use in the method - Google Patents
Method for screening ligand affinity and tool for use in the method Download PDFInfo
- Publication number
- WO2000014541A1 WO2000014541A1 PCT/SE1999/001485 SE9901485W WO0014541A1 WO 2000014541 A1 WO2000014541 A1 WO 2000014541A1 SE 9901485 W SE9901485 W SE 9901485W WO 0014541 A1 WO0014541 A1 WO 0014541A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ligand
- solid phase
- teeth
- target substance
- affinity
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
- G01N33/548—Carbohydrates, e.g. dextran
Definitions
- the technical fields of the invention are methods and tools for determining a) the solid-phase-linked affinity ligands for a predetermined target substance in a library of compounds (ligand candidates) and/or a target substance for a predetermined affinity ligand in a library of target substance candidates, b) suitable conditions (fluid variables) for affinity adsorption and/ or for desorption of an affinity adsorbing target substance, and c) suitable solid phase variables for affinity adsorption and desorption.
- Fluid variables comprise variations of, amongst others, the target substance.
- Solid phase variables include variations of, amongst others, ligands linked to the solid phase.
- affinity binders means that two substances (ligand respectively target substance) selectively/ specifically can bind to each other by affinity.
- the complex which is formed contains the ligand and the target substance. If the ligand is linked to a solid phase and the target substance is in solution then one speaks about affinity adsorption which implies that the complex is formed on the solid phase. The opposite reaction is called desorption and implies that one starts from a solid-phase-linked complex between the ligand and target substance and sets the conditions in the solutions so that the target substance is liberated from the complex and goes into solution.
- affinity ligands are groups which have a charge (anion exchanging, cation exchanging and amphoteric groups) amphiphilic groups, dipolar groups, bioaff ⁇ ne groups (antibody/ antigen/ hapten, Ig(Fc) -binding protein/Ig, lectin/ carbohydrate, complementary nucleic acids, etc), groups which are able to bind to each other via hydrophobic interaction, ⁇ - ⁇ interaction, tiophilic interaction etc. Affinity adsorption has been used in different chromatographic and batchwise processes.
- ligand and/ or target substance are allowed to vary
- this 10 is popularly called the "screening" of libraries of ligands/ target substances.
- the individual ligands/ target substances are members of the library.
- a library also means a number of different spacers, coupling groups, conditions for adsorption respectively desorption which are to be tested. Libraries have two or more members.
- tools of the comb type is meant a tool which in a common holder has two or more projections (teeth) which in general have the same geometric shape
- the projections can in principle be arranged in different geometric patterns, for example one or more parallel rows, circles etc.
- Tools of the comb type have previously been used in order to perform, in parallel, one or more bioaffine reactions. The specific use has been in the context of quantitative or qualitative
- One of the main objects of the invention is to facilitate "screening" of the earlier mentioned types of libraries in order to find suitable combinations of ligand/target substance and other variables.
- screening of a) libraries of ligands or target substances which are to be used in affinity adsorption in order to find suitable pairs of ligands /target substances b) libraries of conditions in order to find suitable conditions in order to affinity adsorb a predetermined target substance to a predetermined ligand which is linked to a solid phase
- libraries of conditions in order to find suitable conditions for desorbing a target substance which in advance is affinity adsorbed to a solid phase which has a ligand structure which is capable of binding to the target substance.
- a partial object is to in a simple way be able to perform in parallel several test runs which differ among themselves with respect to at least one of the above-mentioned variables.
- Another partial goal is to increase the capacity of affinity adsorbents which are used during the "screening" of libraries in the technical field of the invention.
- a first aspect of the invention is a method as stated in the introductory part. This type of method involves making at least two different adsorption or desorption experiments which each comprise:
- step i.a) above the target substance is dissolved in the fluid and is capable of binding to the target substance.
- the fluid used in step i.b) is preferably devoid of/ deficient in the target substance.
- the fluid is a liquid, typically water or an organic solvent including mixtures that if possible can be aqueous.
- That which is new in the method is that one uses a tool in the shape of a comb with at least two essentially equally long teeth which each have a surface carrying the ligand. If there are three or more teeth then these preferably are arranged in one or more rows (chiefly rectilinear) .
- combs with 96 (like 12x8), 349 (like 16x24), or 1536 (like 22x48) teeth or other formats which are adapted so that the teeth fit in the individual wells in so-called micro titer plates.
- combs which have at least one row of teeth with 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, 16, 22, 24, 48 teeth per row.
- Substantially simultaneous contact between the fluid and surfaces is attained through the teeth of the comb being lowered into the fluid which is present in a well (container) which is common for all the teeth.
- the wells are arranged to permit at least two teeth to simultaneously be lowered into their own respective well, with the preference for that in the latter case there is one well arranged for each tooth.
- Variations (differences) between adsorption or desorption experiments can be achieved in two ways: a) through varying the solid phase or therewith linked substances (solid phase variables) and b) through different teeth being contacted with fluids which differ among themselves with respect to the amount and/ or type of constituent components (fluid variables).
- Examples of solid phase variables are the type of solid phase, coupling chemistry, spacers, ligand structure etc.
- fluid variables are pH, ion strength, type of ions present in the fluid, solvent, denaturing/ structure- decomposing agents, target substances, replacement agents, temperature, type of fluid (for example water, aqueous solutions, mixtures of solvents) etc. In the experiments one or both of the ligand and target substance are the same.
- the fluid which the surfaces are contacted with can be common for all the teeth or also a separate fluid can be used for each tooth. In the last case naturally it is also possible that one or more fluid variables vary between the experiments.
- the teeth surfaces which support the ligands according to the invention have preferably surface area enlargements in the shape of unevennesses or pores.
- Surface area enlargement means increasing of the surface area available for affinity adsorption. Suitable surface area enlargements are often increased by a factor of 2 or more, preferably more than ten, compared with corresponding plane surfaces without any unevennesses or pores. Surface area enlargement can be obtained through roughening of the surface, through attaching particles, which preferably are porous, to the surface, etc. For example, if the teeth have an outer plastic layer one can partially dissolve this with a solvent so that it becomes sticky whereafter one can contact the surface with particles, preferably in the form of a suspension. See further WO-A-9411421.
- the surfaces that shall come into contact with the fluid are hydrophilic.
- the surface may carry hydroxyl, carboxyl, amino, polyethyleneoxyl, carboxamide or other polar or charged or chargeable groups. This applies to both exterior surfaces and surfaces in pores.
- the surfaces from the beginning are hydrophobic then they can be hydrophilized in a number of different ways.
- Known hydrophilization procedures are corona treatment, coating with a hydrophilic polymer, for example a polyhydroxyl polymer or another polymer which has a plurality of said hydrophilic groups, polymerisation to precipitate hydrophilic monomers etc.
- polyhydroxyl polymers which potentially can be used are polysaccharides, such as agarose, dextran, starch, cellulose, pullulan etc, and synthetic polyhydroxyl polymers, such as polyvinyl alcohol and polymers of hydroxyl alkyl (C2-10, chiefly C2-5) acrylate or methacrylate, hydroxyl alkyl (C2-10, chiefly C2-5) vinyl ethers etc. Said polymers can be cross-linked and/ or in some other way derivatised.
- polysaccharides such as agarose, dextran, starch, cellulose, pullulan etc
- synthetic polyhydroxyl polymers such as polyvinyl alcohol and polymers of hydroxyl alkyl (C2-10, chiefly C2-5) acrylate or methacrylate, hydroxyl alkyl (C2-10, chiefly C2-5) vinyl ethers etc. Said polymers can be cross-linked and/ or in some other way derivatised.
- the particles are built up from a polyhydroxyl polymer which preferably can be porous.
- a porous hydrophilic surface has been formed through the surfaces of the teeth being coated with a polyhydroxyl polymer which gives suitable porosity.
- the ligand structure can be linked to the surface either covalently or via biospecific affinity, for example via biotin-strepavidin or via affinity between a high affine antibody and hap ten. Covalent bonding can occur via coupling with carboximide, halogencyan (for example BrCN), N-hydroxysuccinimidyl carboxylate, epoxide or halohydrine or vicinal dihalide, reactive squarate groups, thiol which possibly is activated etc.
- an organic spacer can be positioned between the ligand structure and the solid phase.
- the spacer can contain one or more straight, branched or cyclic saturated or unsaturated hydrocarbon chains (for example Ci-io, chiefly C1-5) which can be substituted with one or more hydrophilic groups according to the above. Ring structures can be aromatic even if this often is not preferred because of their hydrophobocity and possibility for undesired interactions.
- substituents on a hydrocarbon chain can be mentioned lower alkoxy, lower alkylthioxy (C ⁇ -10, chiefly C1-5) and lower alkylamino (preferably C2-10, chiefly C2-5).
- spacer also includes the functional groups which link the spacer directly to the ligand structure respectively to the surface which is exposed to the fluid.
- Coupling of ligands to the solid phase often occurs in two or more stages.
- the first stage often involves one activating the solid phase so that reactive groups are introduced.
- reactive groups are activated hydroxyl or activated amino (for example activated with the help of halogencyan), thiol or activated thiol, N-hydroxysuccinimidyl carboxylate groups, activated squarate groups, epoxy or halohydrine or vicinal dihalide, etc.
- Another aspect of the invention is a tool of the comb type according to the above.
- the tool has a characteristic feature that on each tooth there is a surface, which has had its surface area increased by being made uneven and/or by having pores according to that which was mentioned earlier.
- a secondary aspect of the tool of the invention is that respective teeth surfaces are hydrophilised and possibly provided with reactive groups which can be used in order to link ligands. Among reactive groups can be mentioned specially those which were discussed in the foregoing paragraph.
- affinity adsorbed takes place in a manner known in itself. Consequently after the adsorption stage and the removal of the fluid, which initially contains the target substance candidate, one can investigate the presence of the target substance directly on the surface. Alternatively one contacts the surface with a desorption solvent, whereby the subsequent occurrence of the target substance in a desorption solution is an indication that the target substance earlier was affinity adsorbed to the surface.
- the fluids' capacity (fluid variables) for the desorption of a target substance occurs through determining the presence of the target substance in the respective fluid after that it has been contacted with the surface which contains preadsorbed target substance.
- the chief advantages of the invention are obtained during the compilation of ligands and conditions for adsorption/ desorption, which are to be applied to purification methods which use chromatographic affinity matrices in packed and expanded beds and in batchwise methods.
- the advantages depend to a large extent on that the invention renders it possible in a simple way to imitate and vary the different conditions which are used in these types of purification methods (matrices, coupling chemistry for ligands including possible spacers, conditions for adsorption/ desorption, etc).
- the target substances and ligands can have one or more structural elements selected from for example polypeptide, nucleic acid, hydrocarbon and lipid structures. They can be of completely synthetic origin but can also be partly or completely made from naturally occurring compounds (biomolecules) .
- the ligands were dissolved in DMSO.
- each tooth of the comb being dipped in a separate well containing 15 ⁇ l ligand solution (7 mg ligand/ml DMSO). After coupling (60 min) the uncoupled ligand was washed away with DMSO and thereafter the teeth were washed with distilled water. Remaining unreacted NHS-groups on the teeth were deactivated in buffer (0, 1 M Tris 0, 15 M NaCl pH 8). The teeth were then allowed to stand in a buffer for approximately 5 min before they were transferred to the actual adsorption buffer (20 mM PBS, 0, 15 M NaCl pH 7).
- the teeth were then dipped in wells containing the target protein (BSA) dissolved in the adsorption buffer (10 mg BSA/ml buffer) and were allowed to stand in the wells for approximately 30 min. Thereafter the unbound protein was washed away with adsorption buffer.
- BSA target protein
- Detecting with electrophoresis The comb was placed with its teeth standing in a horizontally cast akrylamide gel with wells which precisely fitted the teeth.
- the gel contained a suitable desorption buffer for the target protein (0, 1 M Tris-glycine, pH 8,8, 0,2% Triton X100 10% isopropanol). After approximately 10 min the combs were removed and electrophoresis started. The run took approximately 1 hour.
- the gel was developed in an Autostainer with Commassie blue whereby the gel was coloured blue at the positions which corresponded to the teeth to which a BSA-binding ligand had coupled via reaction with the NHS-activated gel.
- Example 2 Screening for determining suitable desorption buffers
- Adsorption/ desorption A comb to the teeth of which a ligand (according to example 1) which binds BSA had been coupled, was incubated in buffer (20 mM PBS, 0, 15 M NaCl pH 7) (15 min). Each tooth was then dipped in a radioactively marked protein solution (10 mg BSA/ml, 20 mM PBS, 0, 15 M NaCl, pH 7) whereby BSA was bound to the teeth of the comb. Through being dipped in wells the different teeth were contacted with different desorption buffers. The teeth were then washed with distilled water.
- Bound protein (BSA) remaining on the individual teeth can be determined through the teeth being cut from the comb and placed in "scint" cans containing the scintillation fluid. Thereafter the screening of radioactivity for each tooth can be determined in a scintillation counter wherein the number of counts is proportional to the quantity of BSA which remains on the teeth. The tooth which has the lowest value of protein content has been exposed to the most effective desorption buffer.
- Adsorption Ten combs each having 6 teeth (two of the teeth being coupled with a ligand which is known to bind BSA/HSA, two with a ligand of which the binding capacity to BSA/HSA is unknown and two which lack ligands (blanks)) were dipped in 10 different adsorption buffers each containing 10 mg HSA/ml buffer. The combs were incubated for 15 min before they were washed with the respective buffer. The coupling of the ligands occurred in accordance with example 1.
- Detecting with electrophoresis The combs were placed standing in a horizontally moulded akrylamide gel with wells which fitted the teeth positions.
- the gel contained the suitable desorption buffer for BSA/HSA (0, 1M Tris-glycine pH 8,8, 0,2% Triton X100 10% isopropanol) . After approximately 10 min the combs were removed and electrophoresis started. The run took approximately 1 hour.
- the gel was developed in an Autostainer with Commassie blue. The gel was coloured blue in the positions that corresponded to teeth to which the HSA had bound which indicated that the adsorption buffer for these teeth functioned.
- the known BSA/HSA-binder showed good affinity in all the buffers.
- the ligand with unknown binding capacity showed affinity in two of the buffers.
- the blanks showed no affinity in any of the buffers.
- Example 4 Screening of the binding capacity of different proteins for a certain ligand in the same buffer
- Adsorption The respective tooth on a 7-tooth comb where each tooth is coupled (in accordance with example 1) with one and the same HSA/BSA- binder (ligand) were dipped in 7 separate wells containing 7 different proteins (HSA/BSA, ovalbumin, transferrin, ⁇ -lactoglobulin, serum and blanks) dissolved (10 mg/ml) in buffer (20 mM glycine pH 9). The teeth were incubated in the test solutions for approximately 15 min. Thereafter the teeth were washed with buffer (20 mM glycine pH 9) in order to remove non- bonded sample.
- HSA/BSA 7 different proteins
- Detecting with electrophoresis The comb was placed standing in a horizontally cast akrylamide gel with wells which precisely fitted to the teeth.
- the gel contained the suitable desorption buffer for the protein (0, 1 M Tris-glycine pH 8,8, 0,2% Triton X100 10% isopropanol). After approximately 10 min the combs were removed and the electrophoresis started. The run took approximately 1 hour.
- the gel was developed in an Autostainer with Commassie blue. The gel was coloured blue in the positions which corresponded to teeth where the protein had bonded which indicated that the ligand had affinity to the protein in question.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000569235A JP2002524736A (en) | 1998-09-02 | 1999-08-27 | Method for screening affinity of ligand and tool used for the method |
EP99968714A EP1108214A1 (en) | 1998-09-02 | 1999-08-27 | Method for screening ligand affinity and tool for use in the method |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9802951-5 | 1998-09-02 | ||
SE9802951A SE9802951D0 (en) | 1998-09-02 | 1998-09-02 | Method of screening and tools to use in the method |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000014541A1 true WO2000014541A1 (en) | 2000-03-16 |
Family
ID=20412446
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/SE1999/001485 WO2000014541A1 (en) | 1998-09-02 | 1999-08-27 | Method for screening ligand affinity and tool for use in the method |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1108214A1 (en) |
JP (1) | JP2002524736A (en) |
SE (1) | SE9802951D0 (en) |
WO (1) | WO2000014541A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4567597B2 (en) * | 2003-06-24 | 2010-10-20 | 日本碍子株式会社 | Analytical specimen and method for producing the same |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2114738A (en) * | 1981-11-17 | 1983-08-24 | Unilever Plc | Multiple insert device for immunoassay |
GB2147698A (en) * | 1981-11-17 | 1985-05-15 | Unilever Plc | Test apparatus for immunoassay |
WO1994011529A1 (en) * | 1992-11-06 | 1994-05-26 | Pharmacia Biotech Ab | A method of processing nucleic acid samples |
WO1994018564A1 (en) * | 1993-02-01 | 1994-08-18 | Labsystems Oy | Solid phase immunoassay with carriers matching the shape of sample wells |
WO1996035809A1 (en) * | 1995-05-11 | 1996-11-14 | Avitech Diagnostics Inc | Detection of mismatches by resolvase cleavage on a solid support |
US5618671A (en) * | 1992-06-23 | 1997-04-08 | Pharmacia Biotech Ab | Method and system for molecular-biological diagnostics |
US5759784A (en) * | 1994-05-06 | 1998-06-02 | Pharmacia Biotech Ab | Method of nucleic acid transfer |
-
1998
- 1998-09-02 SE SE9802951A patent/SE9802951D0/en unknown
-
1999
- 1999-08-27 EP EP99968714A patent/EP1108214A1/en not_active Withdrawn
- 1999-08-27 JP JP2000569235A patent/JP2002524736A/en active Pending
- 1999-08-27 WO PCT/SE1999/001485 patent/WO2000014541A1/en not_active Application Discontinuation
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2114738A (en) * | 1981-11-17 | 1983-08-24 | Unilever Plc | Multiple insert device for immunoassay |
GB2147698A (en) * | 1981-11-17 | 1985-05-15 | Unilever Plc | Test apparatus for immunoassay |
US5618671A (en) * | 1992-06-23 | 1997-04-08 | Pharmacia Biotech Ab | Method and system for molecular-biological diagnostics |
WO1994011529A1 (en) * | 1992-11-06 | 1994-05-26 | Pharmacia Biotech Ab | A method of processing nucleic acid samples |
US5618701A (en) * | 1992-11-06 | 1997-04-08 | Pharmacia Biotech Ab | Method of processing nucleic acid samples |
WO1994018564A1 (en) * | 1993-02-01 | 1994-08-18 | Labsystems Oy | Solid phase immunoassay with carriers matching the shape of sample wells |
US5759784A (en) * | 1994-05-06 | 1998-06-02 | Pharmacia Biotech Ab | Method of nucleic acid transfer |
WO1996035809A1 (en) * | 1995-05-11 | 1996-11-14 | Avitech Diagnostics Inc | Detection of mismatches by resolvase cleavage on a solid support |
Non-Patent Citations (2)
Title |
---|
P. FELGNER: "A new Technique of Heterogenous Enzyme-Linked Immunosorbent Assay, Stick-ELISA I. Description of the Technique", ZBL. BAKT. HYG., ABT. ORIG. A, vol. 240, 1978, pages 112 - 117, XP000915586 * |
P. FELGNER: "A new Technique of Heterogenous Enzyme-Linked Immunosorbent Assay, Stick-ELISA II. Application of Stick-ELISA to Antigens of Various Infective Agents", ZBL. BAKT. HYG., ABT. ORIG. A, vol. 240, 1978, pages 118 - 122, XP000885516 * |
Also Published As
Publication number | Publication date |
---|---|
SE9802951D0 (en) | 1998-09-02 |
EP1108214A1 (en) | 2001-06-20 |
JP2002524736A (en) | 2002-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Heegaard et al. | Affinity capillary electrophoresis: important application areas and some recent developments | |
Schiel et al. | Applications of silica supports in affinity chromatography | |
US7691645B2 (en) | Immunosubtraction method | |
US9134306B2 (en) | Integrated high throughput system for the analysis of biomolecules | |
Kline | Handbook of affinity chromatography | |
Jain et al. | Protein purification with polymeric affinity membranes containing functionalized poly (acid) brushes | |
EP1715948B1 (en) | Chromatographic material for the absorption of proteins at physiological ionic strength | |
Hage et al. | Affinity chromatography: a historical perspective | |
Gunasena et al. | Organic monoliths for hydrophilic interaction electrochromatography/chromatography and immunoaffinity chromatography | |
Poddar et al. | Affinity monolith chromatography: A review of general principles and recent developments | |
Pichon et al. | Selective tools for the solid-phase extraction of Ochratoxin A from various complex samples: immunosorbents, oligosorbents, and molecularly imprinted polymers | |
WO2007024825A2 (en) | Immunoaffinity separation and analysis compositions and methods | |
JPS61257236A (en) | Chromatographic separation medium and chromatographic separation method using said medium | |
WO2009102207A1 (en) | Improved chromatography resin, and methods and devices related thereto | |
JP4976391B2 (en) | Isolation of proteins based on isoelectric point using solid buffer | |
Bereli et al. | Antibody purification by concanavalin A affinity chromatography | |
Chen et al. | Immunoaffinity extraction of testosterone by antibody immobilized monolithic capillary with on-line laser-induced fluorescence detection | |
US20040224329A1 (en) | Three-dimensional solid phase extraction surfaces | |
EP1108214A1 (en) | Method for screening ligand affinity and tool for use in the method | |
WO2004100887A2 (en) | Three-dimensional solid phase extraction surfaces | |
JPS6155415B2 (en) | ||
WO2007149280A2 (en) | Recovery of analytes using combinatorial libraries | |
Krishna et al. | A REVIEW ON “AFFINITY CHROMATOGRAPHY | |
Sines et al. | ESSENTIAL GUIDES TO METHOD DEVELOPMENT IN AFFINITY CHROMATOGRAPHY | |
Hage et al. | Liquid Chromatography: Chapter 1. Affinity Chromatography |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1999968714 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 569235 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09763784 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1999968714 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999968714 Country of ref document: EP |